Scout Investments Inc. raised its holdings in Balchem Co. (NASDAQ:BCPC) by 4.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 81,949 shares of the basic materials company’s stock after acquiring an additional 3,200 shares during the period. Scout Investments Inc. owned approximately 0.25% of Balchem worth $9,442,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Sei Investments Co. increased its holdings in shares of Balchem by 2.2% during the 3rd quarter. Sei Investments Co. now owns 31,876 shares of the basic materials company’s stock worth $3,041,000 after buying an additional 683 shares during the last quarter. Van ECK Associates Corp boosted its position in shares of Balchem by 5.5% during the 3rd quarter. Van ECK Associates Corp now owns 37,392 shares of the basic materials company’s stock worth $3,651,000 after purchasing an additional 1,938 shares during the period. Brinker Capital Investments LLC purchased a new position in shares of Balchem during the 3rd quarter worth approximately $269,000. Schonfeld Strategic Advisors LLC purchased a new position in shares of Balchem during the 3rd quarter worth approximately $293,000. Finally, Paloma Partners Management Co purchased a new position in shares of Balchem during the 3rd quarter worth approximately $629,000. Institutional investors and hedge funds own 85.01% of the company’s stock.
Shares of BCPC opened at $124.66 on Thursday. The firm has a market cap of $4.03 billion, a PE ratio of 48.89 and a beta of 0.54. The company’s fifty day moving average is $113.57 and its two-hundred day moving average is $103.07. Balchem Co. has a fifty-two week low of $78.30 and a fifty-two week high of $132.50. The company has a quick ratio of 2.82, a current ratio of 3.95 and a debt-to-equity ratio of 0.25.
Balchem (NASDAQ:BCPC) last announced its quarterly earnings results on Monday, November 2nd. The basic materials company reported $0.83 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.13. The company had revenue of $175.14 million for the quarter, compared to analyst estimates of $177.50 million. Balchem had a net margin of 12.02% and a return on equity of 14.01%. As a group, equities research analysts anticipate that Balchem Co. will post 2.88 earnings per share for the current year.
The firm also recently announced an annual dividend, which will be paid on Friday, January 22nd. Investors of record on Monday, December 28th will be issued a dividend of $0.58 per share. This is a positive change from Balchem’s previous annual dividend of $0.26. The ex-dividend date of this dividend is Thursday, December 24th. This represents a dividend yield of 0.5%. Balchem’s payout ratio is presently 18.18%.
A number of equities analysts recently weighed in on BCPC shares. Zacks Investment Research cut shares of Balchem from a “buy” rating to a “hold” rating in a research report on Friday, January 8th. BidaskClub raised shares of Balchem from a “hold” rating to a “buy” rating in a research report on Thursday, January 7th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $117.67.
In related news, VP Scott C. Mason sold 3,000 shares of Balchem stock in a transaction on Friday, November 13th. The shares were sold at an average price of $103.00, for a total transaction of $309,000.00. Following the transaction, the vice president now owns 9,675 shares in the company, valued at approximately $996,525. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.38% of the company’s stock.
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Featured Story: Cash Flow
Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC).
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.